US4132163001 - ADR

Taking everything into account, **HMY** scores **4** out of 10 in our fundamental rating. **HMY** was compared to 154 industry peers in the **Metals & Mining** industry. **HMY** has an excellent profitability rating, but there are concerns on its financial health. **HMY** has a valuation in line with the averages, but it does not seem to be growing.

In multiple years **HMY** reported negative net income over the last 5 years.

Of the past 5 years **HMY** 4 years had a positive operating cash flow.

The **Return On Invested Capital** of **HMY** (**12.50%**) is better than **84.97%** of its industry peers.

Measured over the past 3 years, the **Average Return On Invested Capital** for **HMY** is in line with the industry average of **9.45%**.

The 3 year average ROIC (**10.21%**) for **HMY** is below the current ROIC(**12.50%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.42% | ||

ROE | 13.87% | ||

ROIC | 12.5% |

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)10.21%

ROIC(5y)7.57%

In the last couple of years the **Operating Margin** of **HMY** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 17.29% | ||

PM | 9.78% | ||

GM | 20.98% |

OM growth 3Y29.1%

OM growth 5Y21.15%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y22.02%

GM growth 5Y12.32%

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so **HMY** is destroying value.

The number of shares outstanding for **HMY** has been increased compared to 1 year ago.

An Altman-Z score of **2.76** indicates that **HMY** is not a great score, but indicates only limited risk for bankruptcy at the moment.

The **Altman-Z score** of **HMY** (**2.76**) is comparable to the rest of the industry.

With a **Debt to Equity ratio** value of **0.16**, **HMY** perfoms like the industry average, outperforming **54.25%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.16 | ||

Debt/FCF | N/A | ||

Altman-Z | 2.76 |

ROIC/WACC0.82

WACC16.14%

A Current Ratio of **1.26** indicates that **HMY** should not have too much problems paying its short term obligations.

A Quick Ratio of **0.79** indicates that **HMY** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.26 | ||

Quick Ratio | 0.79 |

The **Revenue** has been growing by **19.23%** on average over the past years. This is quite good.

EPS 1Y548.25%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q220.73%

Revenue growth 1Y15.55%

Revenue growth 3Y18.99%

Revenue growth 5Y19.23%

Revenue growth Q2Q25.72%

The **Earnings Per Share** is expected to decrease by **-16.52%** on average over the next years. This is quite bad

The **Revenue** is expected to decrease by **-0.22%** on average over the next years.

EPS Next Y84.07%

EPS Next 2Y31.62%

EPS Next 3Y-16.52%

EPS Next 5YN/A

Revenue Next Year15.45%

Revenue Next 2Y7.23%

Revenue Next 3Y-0.22%

Revenue Next 5YN/A

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The **Price/Earnings** ratio is **9.88**, which indicates a very decent valuation of **HMY**.

Compared to an average S&P500 **Price/Earnings** ratio of **25.92**, **HMY** is valued rather cheaply.

A **Price/Forward Earnings** ratio of **5.18** indicates a rather cheap valuation of **HMY**.

96.73% of the companies in the same industry are more expensive than **HMY**, based on the **Price/Forward Earnings** ratio.

The average S&P500 **Price/Forward Earnings** ratio is at **19.00**. **HMY** is valued rather cheaply when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.88 | ||

Fwd PE | 5.18 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

A cheap valuation may be justified as **HMY**'s earnings are expected to decrease with **-16.52%** in the coming years.

PEG (NY)0.12

PEG (5Y)N/A

EPS Next 2Y31.62%

EPS Next 3Y-16.52%

With a **Dividend Yield** of **0.90**, **HMY** pays less dividend than the S&P500 average, which is at **2.64**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.9% |

The dividend of **HMY** decreases each year by **-6.96%**.

Dividend Growth(5Y)-6.96%

Div Incr Years0

Div Non Decr Years0

DPN/A

EPS Next 2Y31.62%

EPS Next 3Y-16.52%

**HARMONY GOLD MNG-SPON ADR**

NYSE:HMY (9/25/2023, 7:04:00 PM)

After market: 4.16 +0.01 (+0.24%)**4.15**

**-0.14 (-3.26%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)08-30 2023-08-30/amc

Earnings (Next)N/A N/A

Inst Owners28.54%

Inst Owner Change-5.01%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap2.56B

Analysts51.43

Price Target4.37 (5.3%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.9% |

Dividend Growth(5Y)-6.96%

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

PT rev (1m)-2.64%

PT rev (3m)19.32%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)4.11%

EPS NY rev (3m)18.95%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.51%

Revenue NY rev (3m)3.98%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.88 | ||

Fwd PE | 5.18 | ||

P/S | 0.98 | ||

P/FCF | N/A | ||

P/OCF | N/A | ||

P/B | 1.39 | ||

P/tB | 1.39 | ||

EV/EBITDA | N/A |

EPS(TTM)0.42

EY10.12%

EPS(NY)0.8

Fwd EY19.3%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS4.25

BVpS2.99

TBVpS2.99

PEG (NY)0.12

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.42% | ||

ROE | 13.87% | ||

ROCE | 16.91% | ||

ROIC | 12.5% | ||

ROICexc | 13.26% | ||

ROICexgc | 13.26% | ||

OM | 17.29% | ||

PM | 9.78% | ||

GM | 20.98% | ||

FCFM | N/A |

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)10.21%

ROIC(5y)7.57%

ROICexc(3y)10.86%

ROICexc(5y)8.17%

ROICexgc(3y)10.9%

ROICexgc(5y)8.23%

ROCE(3y)13.81%

ROCE(5y)10.24%

ROICexcg growth 3Y32.17%

ROICexcg growth 5Y35.67%

ROICexc growth 3Y32.92%

ROICexc growth 5Y36.05%

OM growth 3Y29.1%

OM growth 5Y21.15%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y22.02%

GM growth 5Y12.32%

F-ScoreN/A

Asset Turnover0.86

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.16 | ||

Debt/FCF | N/A | ||

Debt/EBITDA | N/A | ||

Cap/Depr | N/A | ||

Cap/Sales | N/A | ||

Profit Quality | N/A | ||

Current Ratio | 1.26 | ||

Quick Ratio | 0.79 | ||

Altman-Z | 2.76 |

F-ScoreN/A

WACC16.14%

ROIC/WACC0.82

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y548.25%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q220.73%

EPS Next Y84.07%

EPS Next 2Y31.62%

EPS Next 3Y-16.52%

EPS Next 5YN/A

Revenue growth 1Y15.55%

Revenue growth 3Y18.99%

Revenue growth 5Y19.23%

Revenue growth Q2Q25.72%

Revenue Next Year15.45%

Revenue Next 2Y7.23%

Revenue Next 3Y-0.22%

Revenue Next 5YN/A

EBIT growth 1Y112.29%

EBIT growth 3Y53.62%

EBIT growth 5Y44.44%

EBIT Next Year110.82%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A